Orphalan Flies Solo In US After Wilson’s Disease Drug Win
FDA Approves French Firm's Cuvrior
Executive Summary
Naseem Amin, the privately owned group’s CEO, tells Scrip that, just as in Europe, Orphalan has the resources to commercialize Cuvrior in the US: “We understand the market and we don't need external partners."